GLP-1s could be another tool in combating substance use disorder in the workplace

Published January 26, 2026 7:00 AM EST 4 Min Read

A batch of Wegovy drugs sit on a counter. — Adobe Stock

Key Insight: Discover how GLP‑1 drugs may dampen alcohol cravings via brain reward pathways.
What’s at Stake: Workplace productivity, healthcare costs, and safety risk significant exposure if coordination fails.
Forward Look: Employers should prepare for integrating GLP‑1 coverage with screening, counseling, and monitoring.
Source: Bullets generated by AI with editorial review

Reporter

Jimmy Nesbitt is a reporter at Employee Benefit News, where he covers the evolving landscape of workplace benefits, healthcare, retirement, financial wellness and related policy issues. His career … Read full bio

For reprint and licensing requests for this article, click here.

More From Employee Benefit News

Employee benefits

With GLP-1s raising costs, employers are finding new ways to reduce spending

As healthcare expenses approach double-digit increases, employers are looking for savings in waste, care delivery, and plan administration before cutting benefits.

By Jimmy Nesbitt

Reporter

Employee Benefits News

September 8

Healthcare

Employers face a new GLP-1 question: Are the drugs worth it?

As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.

By Jimmy Nesbitt

Reporter

Employee Benefits News

August 19

GLP-1 Coverage: Are Employers Getting a Return?

Benefits Think The GLP-1 workplace revolution has already started

The potential for a healthier lifestyle is extending beyond medication to lifestyle and workplace habits that create change for employees.

August 18

Emelie Fritz

Employee benefits

What to know about GLP-1 demand, expense and alternatives

Multiple experts weigh in on the challenges and considerations benefit leaders need to keep in mind as they make decisions about medication coverage.

By Lee Hafner

Editor

Employee Benefit News

August 14

GLP-1 medication with money underneath; expensive

Healthcare

GLP-1s push health plan costs to 15-year high

Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.

By Jimmy Nesbitt

Reporter

Employee Benefits News

August 10

Woman holding multiple GLP-1 injection pens, weight loss and diabetes treatment concept.